Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    April 2018
  1. PINAZZA M, Ghisi M, Minuzzo S, Agnusdei V, et al
    Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
    Oncogene. 2018 Apr 12. pii: 10.1038/s41388-018-0234.
    PubMed     Text format     Abstract available


    March 2018
  2. ZHU Y, Lu L, Qiao C, Shan Y, et al
    Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0157.
    PubMed     Text format     Abstract available


    February 2018
  3. ABDUL-AZIZ AM, Shafat MS, Sun Y, Marlein CR, et al
    HIF1alpha drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
    Oncogene. 2018 Feb 28. pii: 10.1038/s41388-018-0151.
    PubMed     Text format     Abstract available


  4. DI COSTANZO A, Del Gaudio N, Conte L, Dell'Aversana C, et al
    The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0143.
    PubMed     Text format     Abstract available


  5. WANG H, Bei L, Shah CA, Huang W, et al
    The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Oncogene. 2018 Feb 20. pii: 10.1038/s41388-018-0131.
    PubMed     Text format     Abstract available


    October 2017
  6. HEYDT Q, Larrue C, Saland E, Bertoli S, et al
    Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  7. ABBACI A, Talbot H, Saada S, Gachard N, et al
    Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  8. SERIO J, Ropa J, Chen W, Mysliwski M, et al
    The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  9. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  10. D'ABUNDO L, Callegari E, Bresin A, Chillemi A, et al
    Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    July 2017
  11. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  12. ZIMMERMANNOVA O, Doktorova E, Stuchly J, Kanderova V, et al
    An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  13. KANG SM, Rosales JL, Meier-Stephenson V, Kim S, et al
    Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  14. GUO A, Lu P, Lee J, Zhen C, et al
    HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment.
    Oncogene. 2017;36:3441-3449.
    PubMed     Text format     Abstract available


  15. TSURUTA-KISHINO T, Koya J, Kataoka K, Narukawa K, et al
    Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Oncogene. 2017;36:3300-3311.
    PubMed     Text format     Abstract available


    April 2017
  16. BURGESS M, Mapp S, Mazzieri R, Cheung C, et al
    Increased FcgammaRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
    Oncogene. 2017;36:2366-2376.
    PubMed     Text format     Abstract available


  17. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  18. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Text format     Abstract available


    March 2017
  19. TSAI CT, So CW
    Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Oncogene. 2017;36:1753-1759.
    PubMed     Text format     Abstract available


  20. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  21. FERREIRA HJ, Heyn H, Vizoso M, Moutinho C, et al
    DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format    


    February 2017
  22. VAN ATTEKUM MH, Terpstra S, Slinger E, von Lindern M, et al
    Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  23. WAKIM J, Arman E, Becker-Herman S, Kramer MP, et al
    The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  24. PRANGE KH, Mandoli A, Kuznetsova T, Wang SY, et al
    MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  25. UGALE A, Sawen P, Dudenhoffer-Pfeifer M, Wahlestedt M, et al
    MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  26. POMEROY EJ, Lee LA, Lee RD, Schirm DK, et al
    Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  27. SAFFERTHAL C, Rohde K, Fulda S
    Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  28. GOYAMA S, Shrestha M, Schibler J, Rosenfeldt L, et al
    Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  29. SMITH CI
    From identification of the BTK kinase to effective management of leukemia.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  30. STAFFAS A, Arabanian LS, Wei SY, Jansson A, et al
    Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Oncogene. 2016 Sep 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  31. HU Y, Su H, Liu C, Wang Z, et al
    DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  32. LEE-SHERICK AB, Eisenman KM, Sather S, McGranahan A, et al
    Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    


    June 2016
  33. ELF S, Lin R, Xia S, Pan Y, et al
    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  34. BERNASCONI-ELIAS P, Hu T, Jenkins D, Firestone B, et al
    Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  35. SU R, Dong L, Zou D, Zhao H, et al
    microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  36. LIU PP, Liu J, Jiang WQ, Carew JS, et al
    Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2016
  37. SLANY RK
    The molecular mechanics of mixed lineage leukemia.
    Oncogene. 2016 Feb 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  38. RODRIGUEZ-PERALES S, Torres-Ruiz R, Suela J, Acquadro F, et al
    Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors.
    Oncogene. 2016;35:125-34.
    PubMed     Text format     Abstract available


  39. WIMMER P, Berscheminski J, Blanchette P, Groitl P, et al
    PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
    Oncogene. 2016;35:69-82.
    PubMed     Text format     Abstract available


    December 2015
  40. ZHAO Y, Masiello D, McMillian M, Nguyen C, et al
    CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.
    Oncogene. 2015 Dec 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  41. MARJON KD, Termini CM, Karlen KL, Saito-Reis C, et al
    Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
    Oncogene. 2015 Nov 23. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  42. SHAIN KH, Dalton WS, Tao J
    The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
    Oncogene. 2015;34:4673-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: